CONTINENTAL STRATEGY, LLC

Lobbying for IMMIX BIOPHARMA, INC. · A clinical-stage biopharmaceutical company.

Filing 1st Quarter - Report (No Activity)

1st Quarter (Jan 1 - Mar 31) 2026 · California · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem